{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:26:32Z","timestamp":1758039992511,"version":"3.44.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.ahj.2013.07.005","type":"journal-article","created":{"date-parts":[[2013,8,6]],"date-time":"2013-08-06T01:33:43Z","timestamp":1375752823000},"page":"414-420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Overview of the 2012 Food and Drug Administration circulatory system devices panel meeting on the reclassification of external counterpulsation, intra-aortic balloon pump, and non\u2013roller-type cardiopulmonary bypass blood pump devices"],"prefix":"10.1016","volume":"166","author":[{"given":"Sa'ar","family":"Minha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omid","family":"Fatemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Torguson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2013.07.005_bb0005","unstructured":"Food and Drug Administration. Introduction and Regulatory Reference Sheet. Circulatory Devices Advisory Panel December 5\u20136, 2012. http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/MedicalDevices\/MedicalDevicesAdvisoryCommittee\/CirculatorySystemDevicesPanel\/UCM330365.pdf. Accessed January 10, 2013."},{"key":"10.1016\/j.ahj.2013.07.005_bb1005","unstructured":"Food and Drug Administration. 21 CFR 860.93 - Classification of Implants, Life Supporting or Life-Sustaining Devices. Available at: http:\/\/www.gpo.gov\/fdsys\/pkg\/CFR-2011-title21-vol8\/pdf\/CFR-2011-title21-vol8-sec860-93.pdf. Accessed January 10, 2013."},{"key":"10.1016\/j.ahj.2013.07.005_bb0010","unstructured":"Food and Drug Administration. Sec. 515; Sec. 360e - Premarket approval. http:\/\/www.gpo.gov\/fdsys\/pkg\/USCODE-2010-title21\/pdf\/USCODE-2010-title21-chap9-subchapV-partA-sec360e.pdf. Accessed January 10, 2012."},{"key":"10.1016\/j.ahj.2013.07.005_bb0020","unstructured":"Food and Drug Administration. Medical Devices; Order for Certain Class III Devices; Submission of Safety and Effectiveness Information. http:\/\/www.gpo.gov\/fdsys\/pkg\/FR-2009-04-09\/html\/E9-8022.htm. Accessed January 10, 2013."},{"key":"10.1016\/j.ahj.2013.07.005_bb0025","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jacc.2007.07.024","article-title":"Enhanced external counterpulsation and future directions: step beyond medical management for patients with angina and heart failure","volume":"50","author":"Manchanda","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2013.07.005_bb0030","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.amjcard.2006.01.053","article-title":"Effect of external counterpulsation on plasma nitric oxide and endothelin-1 levels","volume":"98","author":"Akhtar","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2013.07.005_bb0035","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1253\/jcj.63.407","article-title":"Improvement of regional myocardial and coronary blood flow reserve in a patient treated with enhanced external counterpulsation: evaluation by nitrogen-13 ammonia PET","volume":"63","author":"Masuda","year":"1999","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.ahj.2013.07.005_bb0040","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0735-1097(99)00140-0","article-title":"The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes","volume":"33","author":"Arora","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2013.07.005_bb0045","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2261-8-39","article-title":"Enhanced external counter pulsation in treatment of refractory angina pectoris: two year outcome and baseline factors associated with treatment failure","volume":"8","author":"Erdling","year":"2008","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.ahj.2013.07.005_bb0050","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-2796.2005.01604.x","article-title":"The immediate and long-term outcome of enhanced external counterpulsation in treatment of chronic stable refractory angina","volume":"259","author":"Loh","year":"2006","journal-title":"J Intern Med"},{"key":"10.1016\/j.ahj.2013.07.005_bb0055","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.amjcard.2011.01.021","article-title":"Effects of enhanced external counterpulsation on arterial stiffness and myocardial oxygen demand in patients with chronic angina pectoris","volume":"107","author":"Casey","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2013.07.005_bb0060","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jacc.2005.10.079","article-title":"Enhanced external counterpulsation improves exercise tolerance in patients with chronic heart failure","volume":"48","author":"Feldman","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2013.07.005_bb0065","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0002-8703(62)90012-1","article-title":"Diastolic balloon pumping (with carbon dioxide) in the aorta\u2014a mechanical assistance to the failing circulation","volume":"63","author":"Moulopoulos","year":"1962","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2013.07.005_bb0070","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0735-1097(03)00400-5","article-title":"Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry","volume":"41","author":"Stone","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2013.07.005_bb0075","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0735-1097(97)00227-1","article-title":"Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries","volume":"30","author":"Anderson","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2013.07.005_bb0080","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1161\/01.CIR.0000085068.59734.E4","article-title":"Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial infarction complicated by cardiogenic shock","volume":"108","author":"Chen","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2013.07.005_bb0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11239-005-0938-0","article-title":"Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial","volume":"19","author":"Ohman","year":"2005","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.ahj.2013.07.005_bb0090","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/eurheartj\/14.1.71","article-title":"Intra-aortic balloon counterpulsation improves survival in cardiogenic shock complicating acute myocardial infarction","volume":"14","author":"Waksman","year":"1993","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2013.07.005_bb0095","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2013.07.005_bb0100","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/jama.2011.1280","article-title":"Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial","volume":"306","author":"Patel","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2013.07.005_bb0105","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.carrev.2012.08.001","article-title":"The impact of intra-aortic balloon counter-pulsation on in-hospital mortality in patients presenting with anterior ST-elevation myocardial infarction without cardiogenic shock","volume":"13","author":"Mahmoudi","year":"2012","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.ahj.2013.07.005_bb0110","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1510\/icvts.2008.196105","article-title":"Prophylactic intra-aortic balloon pump in high-risk patients undergoing coronary artery bypass grafting: a propensity score analysis","volume":"9","author":"Miceli","year":"2009","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.ahj.2013.07.005_bb0115","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.ahj.2005.01.043","article-title":"The preoperative intraaortic balloon pump in coronary bypass surgery: a lack of evidence of effectiveness","volume":"150","author":"Baskett","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2013.07.005_bb0120","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1067\/mtc.2000.110459","article-title":"Prophylactic value of preincision intra-aortic balloon pump: analysis of a statewide experience","volume":"120","author":"Holman","year":"2000","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ahj.2013.07.005_bb0125","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1510\/icvts.2006.140160","article-title":"Intra-aortic balloon counterpulsation in decompensated cardiomyopathy patients: bridge to transplantation or assist device","volume":"6","author":"Norkiene","year":"2007","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.ahj.2013.07.005_bb0130","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1161\/CIRCULATIONAHA.108.830174","article-title":"Evolution of cardiopulmonary bypass","volume":"119","author":"Stoney","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2013.07.005_bb0135","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1525-1594.2012.01497.x","article-title":"Centrifugal pump and roller pump in adult cardiac surgery: a meta-analysis of randomized controlled trials","volume":"36","author":"Saczkowski","year":"2012","journal-title":"Artif Organs"},{"key":"10.1016\/j.ahj.2013.07.005_bb0140","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/eurheartj\/ehp292","article-title":"Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials","volume":"30","author":"Cheng","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2013.07.005_bb0145","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.jacc.2008.05.065","article-title":"A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction","volume":"52","author":"Seyfarth","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2013.07.005_bb0150","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/eurheartj\/ehi161","article-title":"Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock","volume":"26","author":"Thiele","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2013.07.005_bb0155","doi-asserted-by":"crossref","first-page":"469.e1-8","DOI":"10.1016\/j.ahj.2006.05.031","article-title":"A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock","volume":"152","author":"Burkhoff","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2013.07.005_bb0160","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/j.jacc.2009.09.018","article-title":"Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry","volume":"54","author":"Sjauw","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2013.07.005_bb0165","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcin.2008.11.005","article-title":"A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience","volume":"2","author":"Dixon","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2013.07.005_bb0170","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1161\/CIRCULATIONAHA.112.098194","article-title":"A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study","volume":"126","author":"O'Neill","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2013.07.005_bb0175","doi-asserted-by":"crossref","first-page":"B21","DOI":"10.1016\/j.jacc.2012.08.079","article-title":"TCT-67 impact of hemodynamic support with impella vs intraaortic balloon counterpulsation on prognostically important ischemic endpoints: results from the PROTECT-II trial","volume":"60","author":"Dangas","year":"2012","journal-title":"J Am Coll Cardiol"},{"year":"2011","series-title":"Left ventricular support in high risk PCI patients undergoing extensive revascularization","author":"Popma","key":"10.1016\/j.ahj.2013.07.005_bb0180"},{"year":"2011","series-title":"PROTECT II: a prospective multicenter randomized clinical trial of intra-aortic balloon pump vs impella for hemodynamic support during high risk PCI","author":"O'Neill","key":"10.1016\/j.ahj.2013.07.005_bb0185"},{"key":"10.1016\/j.ahj.2013.07.005_bb0190","first-page":"717","article-title":"Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry","volume":"80","author":"Maini","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2013.07.005_bb0195","doi-asserted-by":"crossref","first-page":"E1522","DOI":"10.1016\/S0735-1097(12)61523-X","article-title":"Impella improves clinical outcomes when extensive revascularization is performed: the PROTECT II Study","volume":"59","author":"Popma","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2013.07.005_bb0200","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jtcvs.2012.01.067","article-title":"The RECOVER I: a multicenter prospective study of Impella 5.0\/LD for postcardiotomy circulatory support","volume":"145","author":"Griffith","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ahj.2013.07.005_bb0205","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S1010-7940(02)00176-8","article-title":"Coronary artery bypass grafting supported with intracardiac microaxial pumps versus normothermic cardiopulmonary bypass: a prospective randomized trial","volume":"22","author":"Meyns","year":"2002","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.ahj.2013.07.005_bb0210","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.carrev.2009.07.006","article-title":"Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?","volume":"11","author":"Syed","year":"2010","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.ahj.2013.07.005_bb0215","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/CIRCULATIONAHA.112.132209","article-title":"Long-term mortality data from the balloon-pump assisted coronary intervention study (BCIS-1): a randomized controlled trial of elective balloon counterpulsation during high-risk PCI","volume":"127","author":"Perera","year":"2013","journal-title":"Circulation"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870313004419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870313004419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:49:22Z","timestamp":1757569762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870313004419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0002870313004419"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2013.07.005","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overview of the 2012 Food and Drug Administration circulatory system devices panel meeting on the reclassification of external counterpulsation, intra-aortic balloon pump, and non\u2013roller-type cardiopulmonary bypass blood pump devices","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2013.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}